Targeting PDK1 for Chemosensitization of Cancer Cells
Open Access
Abstract
Despite the rapid development in the field of oncology, cancer remains the second cause of mortality worldwide, with the number of new cases expected to more than double in the coming years. Chemotherapy is widely used to decelerate or stop tumour development in combination with surgery or radiation therapy when appropriate, and in many cases this improves the symptomatology of the disease. Unfortunately though, chemotherapy is not applicable to all patients and even when it is, there are many cases where a successful initial treatment period is followed by chemotherapeutic drug resistance. This is caused by a number of reasons, ranging from the genetic background of the patient (innate resistance) to the formation of tumour-initiating cells (acquired resistance). In this review, we discuss the potential role of PDK1 in the development of chemoresistance in different types of malignancy, and the design and application of potent inhibitors which can promote chemosensitization.Keywords
Funding Information
- Avner Pancreatic Cancer Foundation
This publication has 124 references indexed in Scilit:
- Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitorsBiochemical Journal, 2013
- Genetic and Pharmacological Inhibition of PDK1 in Cancer CellsJournal of Biological Chemistry, 2011
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Genetic inactivation of AKT1 , AKT2 , and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulationProceedings of the National Academy of Sciences, 2010
- A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphateBritish Journal of Cancer, 2010
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human CancerCancer Cell, 2009
- Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cellsEuropean Journal of Cancer, 2009
- Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem CellsCell Stem Cell, 2008
- An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumoursBritish Journal of Cancer, 2008